PD-1 inhibitor, also called a checkpoint inhibitor, works by exposing cancer cells to attack by the immune system by preventing the cancer cells from blocking an effective immune
Resunab is a new synthetic oral endocannabinoid-mimic drug that preferentially binds to a receptor called CB2 on immune cells and fibroblasts. According to several pre-clinical and ex-vivo models,
Currently, solithromycin is in Phase III development for the treatment of CABP and submission of a new drug application (NDA) is planned for 2016. The company is carrying
Earlier, drisapersen has also secured orphan and fast track status, breakthrough therapy designation, as well as priority review status from the FDA. According to FDA, a rare pediatric
The deal will see Valeant pay all cash, one $500m installment upfront and the remaining next year to Sprout, according to the Wall Street Journal. Under the deal,
Developed for the prescription market and formulated with the patented Microcyn Technology, the product is being made available via the company’s dermatology division IntraDerm Pharmaceuticals. Alevicyn SG Antipruritic
Kineret has been approved for the treatment of systemic juvenile idiopathic arthritis (SJIA), which is a rare form of juvenile chronic arthritis that affects children up to 16
Known as ‘Social Impact Metrics’, the MBA course is created with a view to help nonprofit organizations measure effectiveness of their drives, stated to be critical in keeping
HSDD is a constant absence of sexual thoughts, fantasies, responsiveness and willingness to participate in sexual activity. Addyi is a serotonin 1A receptor agonist and a serotonin 2A
The company has recalled the products as the bottle cap can be cracked open by children who can gain unintended access to the capsules that are used for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.